Table 1.
Baseline Characteristics of 4304 Chinese tuberculosis patients.
Table 2.
Incidence, onset time and seriousness of adverse drug reactions due to directly observed treatment strategy therapy in 4304 Chinese tuberculosis patients.
Table 3.
Causality assessment of adverse drug reactions due to directly observed treatment strategy therapy*.
Table 4.
Symptomatic therapy for adverse drug reactions due to directly observed treatment strategy therapy.
Table 5.
Influence of adverse drug reactions due to directly observed treatment strategy therapy on anti-TB treatment pattern.
Table 6.
Possible risk factors for the smear results at the end of intensive phase and anti- tuberculosis outcomes at the end of consolidation phase, respectively.
Table 7.
Impact of ADRs due to directly observed treatment strategy therapy on smear results at the end of intensive phase and anti-TB treatment outcomes.